Zoetis
Categories
#244
Rank
$78.85B
Marketcap
United States
Country
Heidi Chen (Executive Vice President and, General Counsel)
Glenn David (EVP and Chief Financial Officer)
Pharma and Life Sciences
Summary
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm, it is now a completely independent company.
The company directly markets its products in approximately 45 countries and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.
History
1952: In 1952, the Pfizer Agriculture Division opened a 732-acre research and development facility in Terre Haute, Indiana, called Vigo.
1988: By 1988 the division was renamed Pfizer Animal Health.
1995: The 1995 acquisition of Norden Laboratories from GlaxoSmithKline expanded Pfizer's animal health division into small animal care, including domestic pets.
1997: Actelion profile and corporate video Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland.
2003: Secondary research and development centres were opened in Kalamazoo, Michigan, in 2003.
2012: At the time, it was the largest IPO from a United States company since Facebook's $16 billion IPO on May 18, 2012. Zoetis was founded in July 2012 and is headquartered in New York, NY.“ Records show that Pfizer officially filed for registration of a Class A stock with the United States Securities and Exchange Commission on August 10, 2012.
2013: Zoetis' IPO on February 1, 2013 sold 86.1 million shares for US$ 2.2 billion. On May 22, 2013, The Wall Street Journal reported that Pfizer planned to sell its majority stake in the company.
2015: In November 2015, the company announced it would acquire a developer of aquaculture treatments and diseases, Pharmaq, for $765 million.
2017: In 2017, Zoetis acquired Ireland-based Nexvet, a company with a biologics focused technology and product candidate pipeline.
2018: In May 2018, the company announced its intention to acquire Abaxis for $1.9 billion in cash.
2019: Excludes revenue associated with Client Supply Services, which represented 1% of total 2019 revenue.
2021: In August 2021, Zoetis announced it would buy Jurox, increasing the business' presence in New Zealand, the US, Canada and the UK.
Mission
According to Zoetis, the company mission is: “to strive every day to put customers first because when they thrive, Zoetis all benefit. Leading the way are Zoetis field representatives, who develop beneficial business relationships with customers that endure for years".
Vision
According to Zoetis, the company vision is: “to build on a six-decade history and singular focus on animal health to bring customers quality products, services and a commitment to their businesses".
Key Team
Roxanne Lagano (Executive Vice President, Chief Human Resources Officer and Global Operations)
Wafaa Mamilli (Executive Vice President - Chief Information and Digital Officer)
Abhay Nayak (Executive Vice President, Head of Strategy)
Jeannette Ferran Astorga (Executive Vice President)
Nick Ashton (Executive Vice President and President)
Robert Polzer (Executive Vice President and President)
Tim Bettington (Executive Vice President and President)
Wetteny Joseph (Executive Vice President and Chief Financial Officer)
Juan Ramón Alaix (Chief Executive Officer)
Recognition and Awards
Products and Services
Livestock Pharmaceuticals: Zoetis provides pharmaceutical products for the prevention, treatment, and control of diseases in cattle, pigs, poultry, and sheep.
Companion Animal Pharmaceuticals: Zoetis provides pharmaceutical products for the prevention, treatment, and control of diseases in dogs, cats, and horses.
Livestock Vaccines: Zoetis provides vaccines for the prevention of diseases in livestock, including cattle, pigs, poultry, and sheep.
Companion Animal Vaccines: Zoetis provides vaccines for the prevention of diseases in companion animals, including dogs, cats, and horses.
Parasite Control Products: Zoetis provides products for the control of parasites in livestock and companion animals, including flea and tick control products.
Diagnostic Products: Zoetis provides diagnostic products for the early detection and diagnosis of diseases in animals.
Genetic Testing Services: Zoetis provides genetic testing services for livestock and companion animals, including DNA testing for disease susceptibility and for the selection of animals for breeding purposes.
Animal Health Software and Services: Zoetis provides software and services for animal health management, including herd and flock management tools, data analysis and reporting tools, and veterinary consulting services.
References
https://en.wikipedia.org/wiki/Zoetis
https://www.zippia.com/zoetis-careers-13108/
https://www.crunchbase.com/organization/pfizer-animal-health-2
https://www.companieshistory.com/zoetis/
https://sec.report/CIK/0001555280
https://companiesmarketcap.com/largest-companies-by-revenue/
https://www.reuters.com/markets/companies/ZTS.N/
https://www.cnbc.com/quotes/ZTS
https://pitchbook.com/profiles/company/55147-60
https://www.barrons.com/market-data/stocks/zts
Heidi Chen (Executive Vice President and, General Counsel)
Glenn David (EVP and Chief Financial Officer)
Pharma and Life Sciences